$4.79 -0.06 (-1.24%) Derma Sciences Inc - NASDAQ

Sep. 27, 2016 | 04:00 PM
Last Trade: 4.79
Trade Time: Sep 27 04:00 PM Eastern Daylight Time
Change: -0.06 (-1.24%)
Prev Close: 4.85
Open: 4.88
Bid: 4.77
Ask: 4.79
  1. No results found.
  1. Morning Market Losers

    Benzinga | Nov. 12, 2015 | 09:52AM EST
  2. Derma Sciences Announces Closing of Non-Clinical Aclerastide Toxicology Program

    Benzinga | Jun. 18, 2015 | 07:30AM EST
  3. Derma Sciences Announces Medicare Coverage Reinstated For MEDIHONEY Products with Reimbursable Codes by Centers for Medicare & Medicaid Services

    Benzinga | Jun. 17, 2015 | 07:37AM EST
  4. Earnings Scheduled For March 14, 2014

    Benzinga | Mar. 14, 2014 | 05:29AM EST
  5. Derma Sciences Announces Commencement of Public Offering of Common Stock

    Benzinga | Jan. 23, 2014 | 16:21PM EST
  6. Earnings Scheduled For November 13, 2013

    Benzinga | Nov. 13, 2013 | 04:38AM EST
  7. Derma Sciences Ships First MEDIHONEY over-the-counter Product to Leading U.S. Pharmacy Chain

    Benzinga | Aug. 12, 2013 | 07:19AM EST
  8. Earnings Scheduled For August 12, 2013

    Benzinga | Aug. 12, 2013 | 04:54AM EST
  9. Derma Sciences Begins Enrollment in DSC127 Phase 3 Trial

    Benzinga | Feb. 6, 2013 | 01:11AM EST
  10. UPDATE: Canaccord Maintains Buy Derma Sciences based on Solid Q3, Lowers PT

    Benzinga | Nov. 12, 2012 | 23:45PM EST
  11. Earnings Scheduled For November 12, 2012

    Benzinga | Nov. 11, 2012 | 19:29PM EST
  12. Derma Sciences Launches Medihoney Product in US

    Benzinga | Sep. 6, 2012 | 01:32AM EST
  13. UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Derma Sciences

    Benzinga | Aug. 15, 2012 | 06:23AM EST
  14. Canaccord Genuity Reiterates Buy Rating, $18 PT on Derma Sciences

    Benzinga | Aug. 15, 2012 | 04:44AM EST
  15. Derma Sciences Acquires Global Long-Term Exclusive Rights to NIMBUS Technology from Quick-Med Technologies; $1.3M Upfront Payment

    Benzinga | Jul. 13, 2012 | 01:30AM EST
Trading Center